• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Fundamental Rights for People with ALS/MND and Caregivers

The Fundamental Rights represent the ideal standard for people living with ALS/MND and their caregivers worldwide. These rights guide the Alliance’s work and serve as a shared framework that all member organizations can adopt and promote as conditions, systems, and resources allow. We recognize that some of these rights may not be immediately attainable in all countries. Even so, they reflect what every person living with ALS/MND and every caregiver deserves.

Fundamental Rights for People Living with ALS/MND

Upon diagnosis — or likely diagnosis — people living with ALS/MND have the right to:

  1. Access the highest-quality treatments available.
  2. Access approved drugs.
  3. Access clinical trials.
  4. Receive the highest standard of care.
  5. Receive accurate information, tailored resources, ongoing education, and training that promote health literacy and informed decision-making about ALS/MND.
  6. Make informed choices with respect to:
    • health and support professionals;
    • the setting in which care is received; and
    • the types of treatment or support they receive.
  7. Make end-of-life choices, including the right to accept, decline, or stop treatment within the legal framework of their own country.
  8. Contribute to the design, delivery, and evaluation of healthcare and support systems, including policy, care practices, and research.
  9. The freedom to have the highest possible quality of life, according to their own values and preferences.
  10. Live free from any form of discrimination.
  11. Confidentiality and privacy regarding their personal information, and the ability to provide consent for others to communicate on their behalf.
  12. Receive any available governmental or other financial support, benefits, and entitlements.
  13. Have access to:
    • up-to-date education about clinical genetics in ALS/MND;
    • genetic counselling;
    • genetic testing; and
    • safeguards against genetic discrimination.

Note on genetic rights: Where appropriate, and with education and counselling, blood relatives of people living with ALS/MND should also be offered access to genetic counselling and testing. 

Revised October 2025. Download the PALS Fundamental Rights document (PDF).

Fundamental Rights for Caregivers of People Living with ALS/MND

These rights apply to non-professional caregivers (family members, friends, and others who provide care and support to people living with ALS/MND). Caregivers have the right to:

  1. Be treated with dignity and respect, and be recognized as knowledgeable and experienced in the care of their person with ALS/MND.
  2. Receive comprehensive support and services for their own well-being, including:
    • counselling;
    • emotional support programs;
    • mental health services;
    • social programs;
    • respite care programs; and
    • the ability to seek help as and when they need it.
  3. Receive palliative care advice and services.
  4. Receive bereavement advice and services.
  5. Receive any available financial support, benefits, or entitlements — whether governmental or private — to assist in providing care to their person with ALS/MND.
  6. Access all tools, services, and systems that support their caregiving role, including:
    • education, training, and resources that promote ALS/MND health literacy;
    • the ability to remain with their person with ALS/MND during hospital or clinic admissions;
    • timely access to medical appointments and treatments;
    • the ability to request professional support in daily care and living arrangements; and
    • the ability to communicate directly with the healthcare team, with prior consent from their person with ALS/MND.
  7. Contribute meaningfully to the development, implementation, and evaluation of healthcare and support systems — including policymaking, care practices, and medical research — that affect both themselves and their person with ALS/MND.

Revised October 2025. Download the CALS Fundamental Rights document (PDF).

Survey and Research

The Alliance conducts periodic surveys to assess how these rights are being met worldwide. The 2025 survey is now closed. Findings will be shared late 2026. Read the 2023 Fundamental Rights Survey Report for a detailed assessment of how these rights are being met globally, including data, strengths, and gaps identified across the ALS/MND community. 

  • An Assessment of Fundamental Rights for People Living with ALS/MND Worldwide – 2023 (PDF)
  • An Assessment of Fundamental Rights for Caregivers of People Living with ALS/MND Worldwide – 2023 (PDF)
  • An Assessment of Fundamental Rights for People Living with ALS/MND Worldwide: Quality of Life (PDF)
  • An Assessment of Fundamental Rights for People Living with ALS/MND Worldwide: Multidisciplinary Care (PDF) 
  • An Assessment of Fundamental Rights for People Living with ALS/MND Worldwide: Voice Preservation (PDF)
  • An Assessment of Fundamental Rights for People Living with ALS/MND Worldwide: Genetics (PDF)
  • Emergency Preparedness Toolkit for People Living with ALS/MND (PDF)

United Nations Convention on the Rights of Persons with Disabilities

The Alliance and the PALS/CALS Advisory Council support the United Nations Convention on the Rights of Persons with Disabilities and Optional Protocol. This Convention promotes and protects the human rights and fundamental freedoms of all people with disabilities, including those living with ALS/MND. We place particular emphasis on Articles 9 and 19, which guarantee independence, accessibility, and participation in daily life. Equal access to services — including transportation, housing, healthcare, workplace environments, and information — enables people with ALS/MND to live autonomously and make their own decisions. These principles are embedded within the Fundamental Rights of People Living with ALS/MND.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

  • Rob Tison, USA

    Rob Tison, USA

  • Anna Barrow, UK

    Anna Barrow, UK

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • JP

    JP

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Philip Brindle, England

    Philip Brindle, England

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Lee Millard, England

    Lee Millard, England

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Art Eggert, USA

    Art Eggert, USA

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Jon Newsome, USA

    Jon Newsome, USA

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Mike Small, UK

    Mike Small, UK

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Bayley, Australia

    Bayley, Australia

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Paul Launer, USA

    Paul Launer, USA

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login